Logo image of 1SAN.MI

SANOFI (1SAN.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:1SAN - FR0000120578 - Common Stock

79.55 EUR
+0.66 (+0.84%)
Last: 1/22/2026, 7:00:00 PM
Fundamental Rating

4

1SAN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of 1SAN while its profitability can be described as average. 1SAN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • 1SAN had positive earnings in the past year.
  • In the past 5 years 1SAN has always been profitable.
  • Each year in the past 5 years 1SAN had a positive operating cash flow.
1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCF1SAN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 10.63%, 1SAN is in the better half of the industry, outperforming 75.93% of the companies in the same industry.
  • 1SAN has a Return On Equity of 18.84%. This is in the better half of the industry: 1SAN outperforms 62.96% of its industry peers.
  • 1SAN has a Return On Invested Capital of 13.40%. This is in the better half of the industry: 1SAN outperforms 64.81% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1SAN is significantly below the industry average of 13.93%.
  • The 3 year average ROIC (7.31%) for 1SAN is below the current ROIC(13.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.4%
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1SAN.MI Yearly ROA, ROE, ROIC1SAN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • 1SAN's Profit Margin of 20.63% is fine compared to the rest of the industry. 1SAN outperforms 77.78% of its industry peers.
  • 1SAN's Profit Margin has improved in the last couple of years.
  • 1SAN has a Operating Margin (23.61%) which is in line with its industry peers.
  • 1SAN's Operating Margin has improved in the last couple of years.
  • 1SAN has a Gross Margin of 72.29%. This is comparable to the rest of the industry: 1SAN outperforms 51.85% of its industry peers.
  • In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
1SAN.MI Yearly Profit, Operating, Gross Margins1SAN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

  • 1SAN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • 1SAN has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1SAN has about the same amount of shares outstanding.
  • Compared to 1 year ago, 1SAN has an improved debt to assets ratio.
1SAN.MI Yearly Shares Outstanding1SAN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
1SAN.MI Yearly Total Debt VS Total Assets1SAN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • A Debt/Equity ratio of 0.18 indicates that 1SAN is not too dependend on debt financing.
  • 1SAN has a Debt to Equity ratio of 0.18. This is in the better half of the industry: 1SAN outperforms 75.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.73
WACC7.73%
1SAN.MI Yearly LT Debt VS Equity VS FCF1SAN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • 1SAN has a Current Ratio of 1.06. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.06, 1SAN is doing worse than 72.22% of the companies in the same industry.
  • A Quick Ratio of 0.30 indicates that 1SAN may have some problems paying its short term obligations.
  • The Quick ratio of 1SAN (0.30) is worse than 90.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
1SAN.MI Yearly Current Assets VS Current Liabilites1SAN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

4

3. Growth

3.1 Past

  • 1SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.35%.
  • The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
  • The Revenue has been growing slightly by 2.56% in the past year.
  • Measured over the past years, 1SAN shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.41% on average over the next years.
  • 1SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.47% yearly.
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1SAN.MI Yearly Revenue VS Estimates1SAN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
1SAN.MI Yearly EPS VS Estimates1SAN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.47 indicates a reasonable valuation of 1SAN.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1SAN indicates a rather cheap valuation: 1SAN is cheaper than 83.33% of the companies listed in the same industry.
  • 1SAN is valuated cheaply when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 9.35, the valuation of 1SAN can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1SAN indicates a rather cheap valuation: 1SAN is cheaper than 83.33% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.32, 1SAN is valued rather cheaply.
Industry RankSector Rank
PE 10.47
Fwd PE 9.35
1SAN.MI Price Earnings VS Forward Price Earnings1SAN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 70.37% of the companies in the same industry are more expensive than 1SAN, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.55
1SAN.MI Per share data1SAN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.42
PEG (5Y)2.05
EPS Next 2Y5.23%
EPS Next 3Y5.91%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for 1SAN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SANOFI

BIT:1SAN (1/22/2026, 7:00:00 PM)

79.55

+0.66 (+0.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24
Earnings (Next)01-29
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap193.23B
Revenue(TTM)66.91B
Net Income(TTM)13.80B
Analysts79.31
Price Target101.29 (27.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-5.89%
PT rev (3m)-7.25%
EPS NQ rev (1m)-3.33%
EPS NQ rev (3m)-9.74%
EPS NY rev (1m)-0.63%
EPS NY rev (3m)-1.68%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE 10.47
Fwd PE 9.35
P/S 2.89
P/FCF N/A
P/OCF N/A
P/B 2.64
P/tB 43.96
EV/EBITDA 10.55
EPS(TTM)7.6
EY9.55%
EPS(NY)8.5
Fwd EY10.69%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.54
BVpS30.16
TBVpS1.81
PEG (NY)4.42
PEG (5Y)2.05
Graham Number71.82
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.4%
ROICexc 14.75%
ROICexgc 65.74%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 0.68
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.73%
ROIC/WACC1.73
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
EBIT growth 1Y9.12%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.1%
EBIT Next 3Y13.19%
EBIT Next 5Y10.5%
FCF growth 1Y-19.94%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%

SANOFI / 1SAN.MI FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 4 / 10 to 1SAN.MI.


What is the valuation status of SANOFI (1SAN.MI) stock?

ChartMill assigns a valuation rating of 5 / 10 to SANOFI (1SAN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (1SAN.MI) has a profitability rating of 6 / 10.


How financially healthy is SANOFI?

The financial health rating of SANOFI (1SAN.MI) is 3 / 10.


What is the expected EPS growth for SANOFI (1SAN.MI) stock?

The Earnings per Share (EPS) of SANOFI (1SAN.MI) is expected to grow by 2.37% in the next year.